Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salsalate Therapy for Insulin Resistance
NCT00330733Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2007
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Amigesic in insulin resistance (IR), impaired glucose tolerance (IGT), impaired fasting glucose (IFG), sponsored by VA Office of Research & Development. Started Jan 2007; status: completed.
02
Drugs
Amigesic
03
Conditions
insulin resistance (IR)impaired glucose tolerance (IGT)impaired fasting glucose (IFG)
Beyond the preview
Go deeper on NCT00330733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330733.